Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy
Open Access
- 31 October 2008
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 14 (10), 1163-1171
- https://doi.org/10.1016/j.bbmt.2008.07.015
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chronic Graft-Versus-Host DiseaseDrugs, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- New approaches for preventing and treating chronic graft-versus-host diseaseBlood, 2005
- Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplantsBlood, 2004
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseBlood, 2002
- Development of a prognostic model for grading chronic graft-versus-host diseaseBlood, 2001
- Long-Term Survival and Late Deaths after Allogeneic Bone Marrow TransplantationThe New England Journal of Medicine, 1999
- Health and Functional Status of Long-Term Survivors of Bone Marrow TransplantationAnnals of Internal Medicine, 1997
- Predictors of death from chronic graft-versus-host disease after bone marrow transplantationBlood, 1989
- Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 seattle patientsAmerican Journal Of Medicine, 1980